A Tale of Two States: An Exploration of Disparities in the Proportion of Long-term Care Facility--onset Clostridium difficile Infections in Minnesota and New Mexico
Methods: We analyzed population-based CDI data from January 1, 2011– September 30, 2013. A CDI case was defined as a stool specimen positive for C. difficile obtained from a patient without a C. difficile-positive specimen in the previous 8 weeks. A CDI case was classified as LTCF-onset if positive stool specimen was collected in a LTCF or within 3 days after hospital admission from a LTCF. A medical record review was performed on all LTCF-onset CDI cases in MN and a 10% random sample in NM. LTCF utilization data was obtained from the 2012 Area Resource File. Chi-square test was used for comparisons across the two states.
Results: A total of 1597 and 3289 CDI cases were identified in MN and NM, respectively. Among all CDI cases, MN cases were less likely to be LTCF-onset (6% vs. 26%; p<0.0001). Among cases with full review, no differences were detected between MN and NM in mean age (80 vs. 77 years; p=0.1), recent H2 receptor antagonist (18% vs. 22%; p=0.6), proton pump inhibiter (53% vs. 48%; p=0.6), or antibiotic usage (71% vs. 77%; p=0.4) in the 12 weeks prior to stool collection. MN LTCF-onset cases were more likely to have a positive test as a hospital inpatient (34% vs. 18%; p=0.02). Among persons greater than 65 years, LTCF utilization was higher in MN than NM (5.7% vs 2.9%, p<0.0001) and MN had significantly higher population rate of LTCFs (47 vs. 25 per 100,000 persons; p<0.0001) and LTCF beds (2235 vs. 2832 per 100,000 persons; p<0.0001).
Conclusion: Despite LTCF utilization being higher in MN, this state had a lower proportion of LTCF-onset CDI cases compared to NM. No differences in age or prior use of antibiotics or acid reducing medications were detected between LTCF-onset cases in the two states. Further exploration of the variability in testing and infection control practices in LTCFs is warranted to identify prevention strategies directed to this patient population.
S. M. Holzbauer,
E. C. Phipps, None
See more of: Poster Abstract Session